Abstract:Abstract Genomic instability is the hallmark of various cancers with the increasing accumulation of DNA damage. The application of radiotherapy and chemotherapy in cancer treatment is typically based on this property of cancers. However, the adverse effects including normal tissues injury are also accompanied by the radiotherapy and chemotherapy. Targeted cancer therapy has the potential to suppress cancer cells’ DNA damage response through tailoring therapy to cancer patients lacking specific DNA damage response functions. Obviously, understanding the broader role of DNA damage repair in cancers has became a basic and attractive strategy for targeted cancer therapy, in particular, raising novel hypothesis or theory in this field on the basis of previous scientists’ findings would be important for future promising druggable emerging targets. In this review, we first illustrate the timeline steps for the understanding the roles of DNA damage repair in the promotion of cancer and cancer therapy developed, then we summarize the mechanisms regarding DNA damage repair associated with targeted cancer therapy, highlighting the specific proteins behind targeting DNA damage repair that initiate functioning abnormally duo to extrinsic harm by environmental DNA damage factors, also, the DNA damage baseline drift leads to the harmful intrinsic targeted cancer therapy. In addition, clinical therapeutic drugs for DNA damage and repair including therapeutic effects, as well as the strategy and scheme of relative clinical trials were intensive discussed. Based on this background, we suggest two hypotheses, namely “environmental gear selection” to describe DNA damage repair pathway evolution, and “DNA damage baseline drift”, which may play a magnified role in mediating repair during cancer treatment. This two new hypothesis would shed new light on targeted cancer therapy, provide a much better or more comprehensive holistic view and also promote the development of new research direction and new overcoming strategies for patients.

Research progress in DNA damage checkpoint mechanism

DNA damage checkpoint, damage repair, and genome stability.

Recent advances in DNA damage repair mechanism

DNA Damage Checkpoint Recovery and Cancer Development

Targeting the DNA Repair Pathway for Breast Cancer Therapy: Beyond the Molecular Subtypes.

The DNA damage response: putting checkpoints in perspective

Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.

DNA damage checkpoint kinases in cancer

Research progress on the role and mechanism of DNA damage repair in germ cell development

Exploring DNA Damage and Repair Mechanisms: A Review with Computational Insights

The Roles of DNA Damage Response Machineries in Maintaining Genome Stability&Cellular Homeo-stasis

Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair

DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy

Targeting DNA checkpoint kinases in cancer therapy.

Targeting the checkpoint kinases: chemosensitization versus chemoprotection

DNA Damage and Checkpoint Responses in Adult Stem Cells

New Discoveries on Protein Recruitment and Regulation during the Early Stages of the DNA Damage Response Pathways

Targeting DNA Repair Pathways: Mechanisms and Potential Applications in Cancer Therapy

Research Progresses in Delaying Aging by Targeting DNA Damage Repair

Histone Post-Translational Modification and the DNA Damage Response

DNA Damage Checkpoints in Stem Cells, Ageing and Cancer